Servier is souping up its neurology pipeline with a clinical-stage candidate sourced from U.K. biotech Kaerus Bioscience for a rare genetic disease. The French pharma is offering as much as $450 ...

Therapy is often sought when there is a discrepancy between where you see yourself currently in life and where you would like to be. I will work collaboratively with you to develop a unique treatment ...